Literature DB >> 16740038

Dual-track pathway of bladder carcinogenesis: practical implications.

Philippe E Spiess1, Bogdan Czerniak.   

Abstract

CONTEXT: The concept of a dual-track pathway in bladder carcinogenesis postulates that bladder cancer develops via 2 distinct but somewhat overlapping pathways, termed the papillary and nonpapillary. Approximately 80% of bladder carcinomas consist of superficial exophytic papillary lesions that originate from urothelial hyperplasia. These typically low-grade papillary tumors may recur, but they rarely invade the bladder wall or metastasize. The remaining 15% to 20% of tumors represent high-grade solid nonpapillary bladder carcinoma, which arise from high-grade intraurothelial neoplasia. These tumors aggressively invade the bladder wall and have a high propensity for distant metastasis.
OBJECTIVE: To summarize the scientific literature and provide a clinicopathologic review of the dual-track concept of bladder carcinogenesis with its important implications. DATA SOURCES: Relevant articles indexed in PubMed (National Library of Medicine) between 1974 and 2005.
CONCLUSIONS: Although the characteristics of papillary and nonpapillary tumors are quite dissimilar, current evidence implies that both forms of bladder cancer start as a clinically occult clonal expansion of preneoplastic lesions that occupy large areas of the bladder mucosa.

Entities:  

Mesh:

Year:  2006        PMID: 16740038     DOI: 10.5858/2006-130-844-DPOBCP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  16 in total

1.  Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model.

Authors:  Cheng-Huang Shen; Jia-Jen Shee; Jin-Yi Wu; Yi-Wen Lin; Jiann-Der Wu; Yi-Wen Liu
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC).

Authors:  Courtney Pollard; Steven C Smith; Dan Theodorescu
Journal:  Expert Rev Mol Med       Date:  2010-03-25       Impact factor: 5.600

3.  Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.

Authors:  Charles Chuanhai Guo; Vipulkumar Dadhania; Li Zhang; Tadeusz Majewski; Jolanta Bondaruk; Maciej Sykulski; Weronika Wronowska; Anna Gambin; Yan Wang; Shizhen Zhang; Enrique Fuentes-Mattei; Ashish Madhav Kamat; Colin Dinney; Arlene Siefker-Radtke; Woonyoung Choi; Keith A Baggerly; David McConkey; John N Weinstein; Bogdan Czerniak
Journal:  Eur Urol       Date:  2016-03-15       Impact factor: 20.096

4.  Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.

Authors:  Tadeusz Majewski; Sangkyou Lee; Joon Jeong; Dong-Sup Yoon; Andrzej Kram; Mi-Sook Kim; Tomasz Tuziak; Jolanta Bondaruk; Sooyong Lee; Weon-Seo Park; Kuang S Tang; Woonbok Chung; Lanlan Shen; Saira S Ahmed; Dennis A Johnston; H Barton Grossman; Colin P Dinney; Jain-Hua Zhou; R Alan Harris; Carrie Snyder; Slawomir Filipek; Steven A Narod; Patrice Watson; Henry T Lynch; Adi Gazdar; Menashe Bar-Eli; Xifeng F Wu; David J McConkey; Keith Baggerly; Jean-Pierre Issa; William F Benedict; Steven E Scherer; Bogdan Czerniak
Journal:  Lab Invest       Date:  2008-05-05       Impact factor: 5.662

5.  Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.

Authors:  Hong-Seok Park; Weon Seo Park; Jolanta Bondaruk; Noriyoshi Tanaka; Hiroshi Katayama; Sangkyou Lee; Philippe E Spiess; Jordan R Steinberg; Zhi Wang; Ruth L Katz; Colin Dinney; Keren J Elias; Yair Lotan; Rizwan C Naeem; Keith Baggerly; Subrata Sen; H Barton Grossman; Bogdan Czerniak
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 13.506

6.  Clinical significance of urine heparanase in bladder cancer progression.

Authors:  Itay Shafat; Dov Pode; Tamar Peretz; Neta Ilan; Israel Vlodavsky; Benjamin Nisman
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

7.  Biological similarities between murine chemical-induced and natural human bladder carcinogenesis.

Authors:  Carlos Palmeira; Paula A Oliveira; Catarina Lameiras; Teresina Amaro; Victor M Silva; Carlos Lopes; Lúcio Santos
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

8.  Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia.

Authors:  Sangkyou Lee; Joon Jeong; Tadeusz Majewski; Steven E Scherer; Mi-Sook Kim; Tomasz Tuziak; Kuang S Tang; Keith Baggerly; Herbert Barton Grossman; Jain-Hua Zhou; Lanlan Shen; Jolanta Bondaruk; Saira S Ahmed; Susmita Samanta; Philippe Spiess; Xifeng Wu; Slawomir Filipek; David McConkey; Menashe Bar-Eli; Jean-Pierre Issa; William F Benedict; Bogdan Czerniak
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205

9.  Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome.

Authors:  Hong-Ying Huang; Shahrokh F Shariat; Tung-Tien Sun; Herbert Lepor; Ellen Shapiro; Jer-Tsong Hsieh; Raheela Ashfaq; Yair Lotan; Xue-Ru Wu
Journal:  Hum Pathol       Date:  2007-08-17       Impact factor: 3.466

10.  eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation.

Authors:  Rita Spilka; Christina Ernst; Helmut Bergler; Johannes Rainer; Susanne Flechsig; Alexander Vogetseder; Eva Lederer; Martin Benesch; Andrea Brunner; Stephan Geley; Andreas Eger; Felix Bachmann; Wolfgang Doppler; Peter Obrist; Johannes Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2014-07-29       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.